Replies to post #130353 on Value Microcaps Motherboard

[cliffvb]

LTUS: well written article, Edward. LTUS is my top pick in chinese pharmas. The CEO has never disappointed investors and hopefully the SP will begin to reflect their achievements. The CEO also has stated that he has no interest in issuing shares (diluting) here and will finance company growth with free cash flow from operations.

[2morrowsGains]

LTUS...Nice article. Hopefully Lotus puts out news on the reverse split next week with menion of an uplisting. When they release Y/E #'s in April, EPS should be over $0.80 (post split) which will catch a lot of attention. LTUS could easily be a 50% - 100%++ gainer from here over the next year IMO. Time will tell.